Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Feb 7, 2005; 11(5): 752-755
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.752
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.752
Table 1 Effects of L-NNA and INDO on plasma PGI2 and NO concentrations (mean±SD).
Group | Vehicle (n = 23) | L-NNA (n = 21) | Indo (n = 22) | Heparin (n = 24) |
6-keto-PGF1α (pg/mL) | ||||
SO | 725.53±105.54 | 748.48±67.68 | 336.91±37.05c | 3965.96±976.82c |
IHPH | 1123.85±153.64a | 494.74±145.98ac | 342.86±104.79ac | 2930.61±1400.38c |
PHPH | 891.88±83.11a | 386.54±98.44ac | 266.94±57.63c | 2766.47±506.95c |
NO2-/NO3- (μmol/L) | ||||
SO | 58.79±8.47 | 21.31±1.76c | 55.72±5.33 | 45.28±4.398c |
IHPH | 73.34±4.31a | 40.17±10.32ac | 46.42±7.43ac | 54.02±11.89ac |
PHPH | 75.21±6.89a | 30.45±3.28ac | 54.74±4.39c | 62.06±3.56ac |
Table 2 Effects of L-NNA and INDO on systemic hemodynamics (mean±SD).
Group | Vehicle (n = 23) | L-NNA (n = 21) | Indo (n = 22) | Heparin (n = 24) |
MAP (mmHg) | ||||
SO | 141.86±3.02 | 159.29±1.98c | 145.86±3.72 | 157.33±3.77c |
IHPH | 134.00±1.83a | 161.50±6.14c | 161.14±4.45ac | 137.88±2.17a |
PHPH | 130.29±1.89a | 142.50±4.37ac | 147.71±2.75c | 138.29±4.39ac |
CI (mL/min) | ||||
SO | 28.46±0.58 | 25.34±2.22c | 27.20±0.61 | 23.52±0.72c |
IHPH | 32.03±1.34a | 25.03±1.76c | 28.66±1.63c | 28.39±2.25a |
PHPH | 33.19±0.66a | 28.13±0.51ac | 29.62±1.16ac | 26.67±0.66ac |
TPR (mmHg/mL·min) | ||||
SO | 4.99±0.13 | 6.33±0.60c | 5.36±0.13 | 6.70±0.33c |
IHPH | 4.19±0.18a | 6.48±0.53c | 5.64±0.42c | 4.88±0.36a |
PHPH | 3.93±0.06a | 5.07±0.19ac | 5.00±0.33ac | 5.18±0.21ac |
Table 3 Effects of L-NNA and INDO on systemic and splanchnic hemodynamics (mean±SD).
Group | Vehicle (n = 23) | L-NNA (n = 21) | Indo (n = 22) | Heparin (n = 24) |
FPP (mmHg) | ||||
SO | 6.93±0.35 | 7.29±0.39 | 7.07±0.35 | 7.06±0.39 |
IHPH | 10.29±0.39a | 8.75±0.46ac | 9.28±0.57ac | 9.25±0.65ac |
PHPH | 13.71±0.49a | 10.05±0.45ac | 11.57±0.53ac | 11.07±0.79a |
PVI (mL/min) | ||||
SO | 2.35±0.27 | 1.06±0.20c | 1.63±0.17c | 1.57±0.31c |
IHPH | 3.83±0.64a | 2.34±0.50ac | 2.16±0.59c | 2.05±0.62ac |
PHPH | 7.37±1.56a | 3.71±0.53ac | 3.77±0.81ac | 2.35±0.25ac |
SVR (mmHg/mL·min) | ||||
SO | 58.06±6.95 | 96.18±13.71c | 85.56±8.13c | 99.36±20.26c |
IHPH | 32.96±5.09a | 67.83±14.33ac | 74.75±19.34c | 68.51±22.26ac |
PHPH | 16.39±3.23a | 36.21±5.21ac | 37.52±8.10ac | 54.85±6.71ac |
Table 4 Pearson partial correlations between PGI2, NO levels and hemodynamic parameters.
Hemodynamic parameters | PGI2(deduction of the action of NO) | NO (deduction of the action of PGI2) | ||
R | P | R | P | |
CI | -0.0259 | 0.8218 | 0.552 | 0.0001 |
MAP | -0.1335 | 0.2436 | -0.4572 | 0.0001 |
TPR | 0.0122 | 0.9154 | -0.6053 | 0.0001 |
FPP | 0.2598 | 0.0216 | 0.4659 | 0.0001 |
PVI | 0.1536 | 0.1794 | 0.3579 | 0.0013 |
PVR | -0.0523 | 0.6493 | -0.228 | 0.0446 |
SVR | -0.1216 | 0.2889 | -0.4325 | 0.0001 |
- Citation: Wu ZY, Chen XS, Qiu JF, Cao H. Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats. World J Gastroenterol 2005; 11(5): 752-755
- URL: https://www.wjgnet.com/1007-9327/full/v11/i5/752.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i5.752